LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Voyager Therapeutics (VYGR – Research Report), ...
The stock's rise snapped a seven-day losing streak.
This was the stock's sixth consecutive day of losses.
The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.
Labcorp will acquire the oncology diagnostics operations from BioReference Health as part of a push to expand in high-growth ...
A vehicle crashed into the LabCorp business at 595 Loudon Rd in Newton Plaza II on March 4, causing significant damage to the ...
Truist analyst David MacDonald notes Labcorp (LH) announced that the company has reached an agreement to acquire oncology-focused lab testing ...
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
10d
Zacks Investment Research on MSNShould Labcorp Stock Stay in Your Portfolio Right Now?Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results